2009
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis. Journal Of Women's Health 2009, 18: 311-319. PMID: 19281314, PMCID: PMC2858300, DOI: 10.1089/jwh.2008.0857.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsConfidence IntervalsControlled Clinical Trials as TopicFemaleFertilityFertility Agents, FemaleGonadotropin-Releasing HormoneHumansNeoplasmsOdds RatioOvaryPregnancyPregnancy OutcomePrimary Ovarian InsufficiencyPrognosisYoung AdultConceptsFollicle-stimulating hormoneOvarian functionOvarian preservationGnRH agonistGnRHa therapyRelative riskGnRHa-treated womenOvarian function preservationSummary relative riskRandom-effects modelEnglish-language literaturePremenopausal womenCombination chemotherapyRandomized trialsFunction preservationAutoimmune diseasesOvarian failureHematologic malignanciesMenstrual cycleReproductive agePreservation optionsGnRHaChemotherapyMeeting abstractsSmall study
2005
Impact of the Cancer Risk Intake System on Patient‐Clinician Discussions of Tamoxifen, Genetic Counseling, and Colonoscopy
Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA. Impact of the Cancer Risk Intake System on Patient‐Clinician Discussions of Tamoxifen, Genetic Counseling, and Colonoscopy. Journal Of General Internal Medicine 2005, 20: 360-365. PMID: 15857495, PMCID: PMC1490091, DOI: 10.1111/j.1525-1497.2005.40115.x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAlgorithmsAntineoplastic Agents, HormonalBreast NeoplasmsColonic NeoplasmsColonoscopyCommunicationCounselingFemaleGenetic CounselingHumansMaleMiddle AgedOdds RatioOvarian NeoplasmsPatient Acceptance of Health CarePatient Education as TopicPhysician-Patient RelationsPrimary Health CareRisk AssessmentTamoxifenConceptsPatient-clinician discussionsPrimary care settingCare settingsGenetic counselingBaseline telephone surveyObjective cancer riskMonths postvisitClinic visitsCancer riskTelephone surveyColonoscopySurvey 1TamoxifenPretest-posttest designGreater proportionComputerized programCounselingManagement recommendationsRisk management recommendationsParticipantsPostvisitFollowProportionSettingBaseline
2001
Women's Interest in Chemoprevention for Breast Cancer
Bastian L, Lipkus I, Kuchibhatla M, Weng H, Halabi S, Ryan P, Skinner C, Rimer B. Women's Interest in Chemoprevention for Breast Cancer. JAMA Internal Medicine 2001, 161: 1639-1644. PMID: 11434796, DOI: 10.1001/archinte.161.13.1639.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAttitude to HealthBreast NeoplasmsData CollectionFemaleHumansLogistic ModelsMiddle AgedRandomized Controlled Trials as TopicSocial ClassTamoxifenTelephoneConceptsBreast cancer riskBreast cancerCancer riskGail scoreObjective breast cancer riskMammography decision aidObjective risk factorsDevelopment of cancerAbsolute riskRisk factorsChemopreventive agentsChemopreventionCancerComparative riskTelephone interviewsTamoxifen citrateDrugsWomenRiskNatural agentsCommunity sampleDecision aidScoresTherapyAgents